These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27651507)

  • 1. Efficacy and Safety of Long-Term Administration of Tapentadol in Relieving Chronic Pancreatitis Pain.
    Iacobellis A; Seripa D; Palmieri O; Andriulli N; Latina P
    Pain Med; 2017 Apr; 18(4):815-817. PubMed ID: 27651507
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of tapentadol ER for managing moderate to severe chronic pain.
    Afilalo M; Morlion B
    Pain Physician; 2013 Jan; 16(1):27-40. PubMed ID: 23340531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic mechanism-orientated approach to chronic pancreatitis pain.
    Bouwense SA; de Vries M; Schreuder LT; Olesen SS; Frøkjær JB; Drewes AM; van Goor H; Wilder-Smith OH
    World J Gastroenterol; 2015 Jan; 21(1):47-59. PubMed ID: 25574079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tapentadol Prolonged Release Reduces the Severe Chronic Ischaemic Pain and Improves the Quality of Life in Patients with Type 2 Diabetes.
    Tedeschi A; De Bellis A; Francia P; Bernini A; Perini M; Salutini E; Anichini R
    J Diabetes Res; 2018; 2018():1081792. PubMed ID: 29675431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tapentadol - how does it work in chronic pain?].
    MMW Fortschr Med; 2013 Sep; 155(16):44-5. PubMed ID: 24279155
    [No Abstract]   [Full Text] [Related]  

  • 6. Tapentadol prolonged release for managing moderate to severe, chronic malignant tumor-related pain.
    Kress HG; Koch ED; Kosturski H; Steup A; Karcher K; Lange B; Dogan C; Etropolski MS; Eerdekens M
    Pain Physician; 2014; 17(4):329-43. PubMed ID: 25054392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dual mechanism of action of tapentadol].
    MMW Fortschr Med; 2012 Jun; 154(12):70-1. PubMed ID: 22880304
    [No Abstract]   [Full Text] [Related]  

  • 8. A pooled analysis of patient-specific factors and efficacy and tolerability of tapentadol extended release treatment for moderate to severe chronic pain.
    Etropolski M; Lange B; Goldberg J; Steup A; Rauschkolb C
    J Opioid Manag; 2013; 9(5):343-56. PubMed ID: 24353047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study protocol for a randomised, double-blinded, placebo-controlled, clinical trial of S-ketamine for pain treatment in patients with chronic pancreatitis (RESET trial).
    Juel J; Olesen SS; Olesen AE; Poulsen JL; Dahan A; Wilder-Smith O; Madzak A; Frøkjær JB; Drewes AM
    BMJ Open; 2015 Mar; 5(3):e007087. PubMed ID: 25757947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse event reporting in the recent study by Imanaka et al. describing the efficacy and safety of tapentadol extended release for tumor-related pain.
    Imanaka K; Tominaga Y; Etropolski M; Van Hove I; Ohsaka M; Wanibe M; Hirose K; Matsumura T
    Curr Med Res Opin; 2014 Sep; 30(9):1909-10. PubMed ID: 24818815
    [No Abstract]   [Full Text] [Related]  

  • 11. Pain management in chronic pancreatitis incorporating safe opioid practices: Challenge accepted.
    Shah I; Sheth SG; Kothari DJ
    World J Gastroenterol; 2021 Jun; 27(23):3142-3147. PubMed ID: 34163102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tapentadol extended release for chronic pain patients.
    Taylor R; Pergolizzi JV; Raffa RB
    Adv Ther; 2013 Jan; 30(1):14-27. PubMed ID: 23328938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical Management of Pain in Chronic Pancreatitis.
    Singh VK; Drewes AM
    Dig Dis Sci; 2017 Jul; 62(7):1721-1728. PubMed ID: 28523574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodological Issues in Conducting Pilot Trials in Chronic Pain as Randomized, Double-blind, Placebo-controlled Studies.
    Tominaga Y; Koga H; Uchida N; Wanibe M; Hirose K; Matsumura T; Okamoto A; Richarz U; Etropolski M
    Drug Res (Stuttg); 2016 Jul; 66(7):363-70. PubMed ID: 27224908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism-based pain management in chronic pancreatitis - is it time for a paradigm shift?
    Kuhlmann L; Olesen SS; Olesen AE; Arendt-Nielsen L; Drewes AM
    Expert Rev Clin Pharmacol; 2019 Mar; 12(3):249-258. PubMed ID: 30664364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analgesia in pancreatitis].
    Zdravcević KS; Goranović T
    Lijec Vjesn; 2009; 131 Suppl 3():23-5. PubMed ID: 23120848
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term, prolonged-release oral tapentadol for the treatment of refractory chronic low back pain: a single-center, observational study.
    Finco G; Mura P; Musu M; Deidda C; Saba M; Demelas I; Evangelista M; Sardo S
    Minerva Med; 2018 Aug; 109(4):259-265. PubMed ID: 29947490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From acute to chronic pain: tapentadol in the progressive stages of this disease entity.
    Coluzzi F; Fornasari D; Pergolizzi J; Romualdi P
    Eur Rev Med Pharmacol Sci; 2017 Apr; 21(7):1672-1683. PubMed ID: 28429337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 26. Pain in chronic pancreatitis.
    Puylaert M; Kapural L; Van Zundert J; Peek D; Lataster A; Mekhail N; van Kleef M; Keulemans YC
    Pain Pract; 2011; 11(5):492-505. PubMed ID: 21676159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique pharmacology of tapentadol for treating acute and chronic pain.
    Knezevic NN; Tverdohleb T; Knezevic I; Candido KD
    Expert Opin Drug Metab Toxicol; 2015; 11(9):1475-92. PubMed ID: 26215077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.